By Taimour Zaman, Founder, AltFunds Global
Software-as-a-service remains one of the most attractive verticals for growth capital providers: recurring revenues, high scalability, and defensible unit economics. But since the 2022 market correction, growth equity has redefined its criteria. Profitability and efficient growth now outweigh top-line momentum. For SaaS founders, the challenge is not accessing capital. It is identifying providers with the right stage focus, operating expertise, and tolerance for long-cycle returns.
The state of SaaS growth capital
Capital has concentrated. Since the 2021 peak, growth equity deployment into SaaS has fallen materially, and the capital that remains flows into proven platforms rather than being spread across speculative bets. Four shifts define the current market:
- Efficiency first. Providers prioritize ARR per employee, net dollar retention, and payback periods over pure ARR growth.
- Rise of hybrid structures. Minority growth equity is increasingly paired with structured equity or venture debt to reduce dilution.
- Sector specialization. Vertical SaaS (healthcare IT, fintech SaaS, supply chain SaaS) commands premium valuations relative to horizontal SaaS.
- M&A as a growth lever. Providers often underwrite growth via roll-ups, acquiring complementary SaaS products to expand the addressable market.
Case study: Toast
Toast, the restaurant SaaS platform, shows what growth capital can do at scale. After raising $400 million in growth equity from TPG, Tiger Global, and Greenoaks in 2020, Toast expanded aggressively into payments and hardware integration. By its 2021 IPO it had surpassed $1.7 billion in ARR. The capital was catalytic, but the ride was volatile: its market cap halved during the 2022 tech sell-off before stabilizing as the market rewarded improved operating leverage. The lesson holds for any founder: the provider matters, and so does the durability of the model the capital is poured into.
Leading growth capital providers for SaaS
Providers with a deep SaaS track record include:
- Vista Equity Partners: global leader in software growth and buyouts with a heavy operational focus.
- Thoma Bravo: scales SaaS platforms through buy-and-build strategies.
- TA Associates: classic growth equity firm with a deep SaaS portfolio.
- JMI Equity: longtime SaaS specialist focused on growth rounds.
- Accel-KKR: hybrid venture and growth model, strong in mid-market SaaS.
- Great Hill Partners: active in B2B SaaS and fintech SaaS.
- Francisco Partners: large-scale software transactions, including SaaS carve-outs.
- Serent Capital: focused on founder-owned SaaS businesses with operating support.
Non-dilutive alternatives
For founders who want growth capital without giving up the company, several specialists lend against recurring revenue rather than taking equity:
- SaaS Capital: ARR-based credit facilities.
- River SaaS Capital: growth debt with flexible structures.
- Novel Capital: non-dilutive SaaS financing.
- Espresso Capital and Timia Capital: revenue-based financing and venture debt.
Revenue-based structures repay against revenue performance rather than fixed amortization, which keeps the cap table intact and control with the founder.
Trade-offs, risks, and opportunities
- Dilution vs. control: growth equity often demands board influence; debt limits dilution but raises repayment risk.
- Exit environment: IPO windows for SaaS are narrow; secondary sales and sponsor-to-sponsor transactions dominate.
- Market saturation: horizontal SaaS faces margin compression; vertical SaaS offers more defensible niches.
- The opportunity: providers continue to prize SaaS companies with efficient customer acquisition and high retention in recession-resistant verticals.
Conclusion
SaaS growth capital remains plentiful but concentrated among sophisticated providers that value efficiency and long-term defensibility. Founders should weigh the cost of dilution against the benefits of strategic partners who deliver operating expertise, M&A integration, and a path to public markets or strategic acquisition. And founders with strong recurring revenue should know the non-dilutive lane exists before they sign away equity they did not need to sell.
Weighing dilution against debt for your next stage? Visit us at AltFunds Global.
Disclaimer
This article is provided for general educational and informational purposes only. It does not constitute financial, legal, or tax advice, and it is not an offer, solicitation, or recommendation to buy or sell any financial instrument. References to third-party firms are illustrative market references, not endorsements or recommendations. AltFunds Global is a global financial advisory firm; it is not a bank, lender, fund, custodian, broker-dealer, or placement agent. Readers should seek independent professional advice (legal, tax, financial) before making any decisions. Past case studies do not guarantee future results. No liability is accepted for any loss arising from the use of this material.